Alzheimer's disease: a re-examination of the amyloid hypothesis
暂无分享,去创建一个
[1] R. Wurtman,et al. Neuronal Expression of β-Amyloid Precursor Protein Alzheimer Mutations Causes Intracellular Accumulation of a C-terminal Fragment Containing Both the Amyloid β and Cytoplasmic Domains* , 1997, The Journal of Biological Chemistry.
[2] J. Pettegrew,et al. Aggregation of β‐Amyloid Peptide Is Promoted by Membrane Phospholipid Metabolites Elevated in Alzheimer's Disease Brain , 1997 .
[3] M. Mattson,et al. Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.
[4] M. Shapiro,et al. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein , 1997, Nature.
[5] I. Grundke‐Iqbal,et al. Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles , 1997, Molecular Psychiatry.
[6] R. Reiter,et al. Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide , 1997, The Journal of Neuroscience.
[7] H. Nakanishi,et al. Increased Expression of Cathepsins E and D in Neurons of the Aged Rat Brain and Their Colocalization with Lipofuscin and Carboxy‐Terminal Fragments of Alzheimer Amyloid Precursor Protein , 1997, Journal of neurochemistry.
[8] H. Wiśniewski,et al. The “Nonamyloidogenic” p3 Fragment (Amyloid β17-42) Is a Major Constituent of Down's Syndrome Cerebellar Preamyloid* , 1996, The Journal of Biological Chemistry.
[9] T. Sunderland,et al. Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation , 1996, Science.
[10] L. Mucke,et al. β-Secretase Processing of the β-Amyloid Precursor Protein in Transgenic Mice Is Efficient in Neurons but Inefficient in Astrocytes* , 1996, The Journal of Biological Chemistry.
[11] G. Elder,et al. Age-dependent spatial memory deficits in transgenic mice expressing the human mid-sized neurofilament gene: I. , 1996, Brain research. Molecular brain research.
[12] R. Neve,et al. Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein , 1996, The Journal of Neuroscience.
[13] Allan I. Levey,et al. Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.
[14] J. Hardy,et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.
[15] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[16] Hans Förstl,et al. Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay* , 1996, The Journal of Biological Chemistry.
[17] G. Pasinetti. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: The role of the complement system , 1996, Neurobiology of Aging.
[18] F. Maxfield,et al. Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor , 1996, Neuron.
[19] J. Loike,et al. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils , 1996, Nature.
[20] X. Chen,et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.
[21] D. Selkoe,et al. Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.
[22] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[23] H. Soininen,et al. Apolipoprotein E, memory and Alzheimer's disease , 1996, Trends in Neurosciences.
[24] S. Takeda,et al. G Protein-Mediated Neuronal DNA Fragmentation Induced by Familial Alzheimer's Disease-Associated Mutants of APP , 1996, Science.
[25] P. Gottschall,et al. Increased Production of Matrix Metalloproteinases in Enriched Astrocyte and Mixed Hippocampal Cultures Treated with β‐Amyloid Peptides , 1996 .
[26] K. Brunden,et al. Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro , 1996, Neurobiology of Aging.
[27] S. Takeda,et al. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait‐linked phenotype. , 1996, The EMBO journal.
[28] R. Quirion,et al. Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[29] M. Lalowski,et al. Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs. , 1996, The Biochemical journal.
[30] M. V. Hogan,et al. Surface Phosphorylation by Ecto‐Protein Kinase C in Brain Neurons: A Target for Alzheimer's β‐Amyloid Peptides , 1995, Journal of neurochemistry.
[31] Carl W. Cotman,et al. Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro(*) , 1995, The Journal of Biological Chemistry.
[32] R. Wolfert,et al. Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease , 1995 .
[33] W. V. Van Nostrand,et al. Amyloid β-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro(*) , 1995, The Journal of Biological Chemistry.
[34] C. Arias,et al. β‐Amyloid peptide fragment 25–35 potentiates the calcium‐dependent release of excitatory amino acids from depolarized hippocampal slices , 1995, Journal of neuroscience research.
[35] D. Ferrari,et al. Activation of microglial cells by β-amyloid protein and interferon-γ , 1995, Nature.
[36] Mark A. Smith,et al. Radical AGEing in Alzheimer's disease , 1995, Trends in Neurosciences.
[37] S. Younkin. Evidence that Aβ42 is the real culprit in alzheimer's disease , 1995 .
[38] J. Whitson,et al. Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade , 1995, Neurobiology of Aging.
[39] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[40] J. Poirier. Apolipoprotein E in animal models of CNS injury and in alzheimer's disease , 1994, Trends in Neurosciences.
[41] S. Rapoport,et al. β-Amyloid polypeptide increases calcium-uptake in PC12 cells: a possible mechanism for its cellular toxicity in Alzheimer's disease , 1994, Brain Research.
[42] A. Privat,et al. Inhibitors of free radical formation fail to attenuate direct β‐amyloid25–35 peptide‐mediated neurotoxicity in rat hippocampal cultures , 1994, Journal of neuroscience research.
[43] W. Klein,et al. Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide. , 1994, The Journal of biological chemistry.
[44] L. Thal,et al. Lack of long-term effects after β-amyloid protein injections in rat brain , 1994, Neurobiology of Aging.
[45] M. Mattson,et al. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation , 1994, Brain Research.
[46] C. Behl,et al. Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.
[47] C. Behl,et al. Amyloid β peptide induces necrosis rather than apoptosis , 1994, Brain Research.
[48] M. Ball,et al. Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. , 1994, The Journal of biological chemistry.
[49] D L Alkon,et al. Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. , 1994, Science.
[50] J. Morrison,et al. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. , 1994, Cerebral cortex.
[51] T. Holzman,et al. Similarities between β Amyloid Peptides 1-40 and 40-1: Effects on Aggregation, Toxicity in Vitro, and Injection in Young and Aged Rats , 1994, Experimental Neurology.
[52] R. Porter,et al. NMDA and AMPA Receptors in Transgenic Mice Expressing Human β‐Amyloid Protein , 1993 .
[53] Mark P. Mattson,et al. β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease , 1993, Trends in Neurosciences.
[54] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[55] S. B. Kater,et al. An analysis of the effects of Alzheimer's plaques on living neurons , 1993, Neurobiology of Aging.
[56] Khadija Iqbal,et al. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. , 1993, Archives of biochemistry and biophysics.
[57] M. Mattson,et al. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.
[58] N. Robakis,et al. The genesis of the senile plaque. Further evidence in support of its neuronal origin. , 1992, The American journal of pathology.
[59] D. Stephenson,et al. In vivo effects of β-amyloid implants in rodents: lack of potentiation of damage associated with transient global forebrain ischemia , 1992, Brain Research.
[60] Bradley T. Hyman,et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.
[61] G. Carlson,et al. Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory , 1991, Neuroreport.
[62] K. Crutcher,et al. Neurite outgrowth on postmortem human brain cryostat sections: Studies of non-alzheimer's and alzheimer's tissue , 1991, Experimental Neurology.
[63] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[64] M. Chalfie,et al. The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration , 1991, Nature.
[65] D. Kirschner,et al. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.
[66] Dagmar Ringe,et al. A transport problem? , 1990, Nature.
[67] R. Neve,et al. The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects , 1989, Experimental Neurology.
[68] C. Cotman,et al. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.
[69] C. Finch,et al. Molecular Neuropathology of Aging , 1988 .
[70] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[71] Weiming Xia,et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.
[72] C. Bieberich,et al. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice , 1995, Nature Genetics.